Clinical trial

Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure

NCT06669169

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-01-31

PhasePHASE2

Study timeline

Study start (estimated)2025-01-31Date precision: day

Registry last updated2024-11-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Jia Shen Tablet PlaceboDRUG

Low dose Jia Shen TabletDRUG

High dose Jia Shen TabletDRUG

Sponsors & collaborators

Tasly Pharmaceutical Group Co., Ltdlead sponsor

Mapped research locations

TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06669169 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.